Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Chemotherapy, Adjuvant × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 7 Rectal Neoplasms 4 Colorectal Neoplasms 4 Colonic Neoplasms 4 Stomach Neoplasms 2 Neoplasm, Residual 2 Nasopharyngeal Carcinoma 2 Mesothelioma, Malignant 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Solitary Fibrous Tumor, Pleural 1 Sarcopenia 1 Sarcoglycanopathies 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Neoplasm Metastasis 1 NSCLC 1 Microsatellite Instability 1 Mesothelioma 1 Melanoma 1 Malnutrition 1 Lung Neoplasms 1 HER2 Negative Breast Cancer 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Frailty 1 Esophageal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 28 fludarabine 20 Whole-Body Irradiation 19 fludarabine phosphate 18 asciminib 18 Mycophenolic Acid 17 nilotinib 14 Tacrolimus 14 Imatinib Mesylate 12 Melphalan 11 Dasatinib 9 ponatinib 8 bosutinib 8 Thiotepa 8 Peripheral Blood Stem Cell Transplantation 7 Busulfan 7 Mesna 6 Granulocyte Colony-Stimulating Factor 6 Filgrastim 5 venetoclax 4 olverembatinib 4 blinatumomab 4 Stem Cell Transplantation 4 Sirolimus 4 ruxolitinib 3 Rituximab 3 Hematopoietic Stem Cell Transplantation 3 Cyclosporine 3 Bone Marrow Transplantation 3 Azacitidine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡